Growth Metrics

Odyssey Health (ODYY) Non Operating Investment Income (2024 - 2025)

Odyssey Health's quarterly Non Operating Investment Income came in at -$27364.0 in Q3 2025, down 144.02% year-on-year from $62166.0 in Q3 2024, and up 55.4% quarter-over-quarter from -$61357.0 in Q2 2025.

Odyssey Health has reported Non Operating Investment Income for 2 years, with the latest figure at -$27364.0 in Q3 2025.

  • For the quarter ending Q3 2025, Non Operating Investment Income fell 144.02% year-over-year to -$27364.0; the trailing twelve-month figure through Jan 2026 stood at -$88721.0 (up 86.88% YoY), and the FY2025 full-year result was -$459417.0, up 71.97% from the prior year.
  • Non Operating Investment Income for Q3 2025 stood at -$27364.0, up from -$61357.0 in the prior quarter.
  • The five-year high for Non Operating Investment Income was $62166.0 in Q3 2024, with the low at -$1.3 million in Q1 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Investment Income (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -55.03 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Odyssey Health - - - -

Historic Data

Download Data 🔒
DateValue
Jul 31, 2025 -27,364.00
Jul 31, 2025 -27,364.00
Apr 30, 2025 -61,357.00
Apr 30, 2025 -61,357.00
Oct 31, 2024 -370,698.00
Oct 31, 2024 -370,698.00
Jul 31, 2024 62,166.00
Jul 31, 2024 62,166.00
Apr 30, 2024 -367,929.00
Apr 30, 2024 -367,929.00
Jan 31, 2024 -1.33 Mn
Jan 31, 2024 -1.33 Mn